Literature DB >> 31551037

Long-Term Outcomes of Indirect Bypass for 629 Children With Moyamoya Disease: Longitudinal and Cross-Sectional Analysis.

Eun Jin Ha1,2,3, Kyung Hyun Kim1,2, Kyu-Chang Wang1,2, Ji Hoon Phi1,2, Ji Yeoun Lee1,4,2, Jung Won Choi5, Byung-Kyu Cho6, Jeyul Yang1,2, Yoon Hwan Byun1,2, Seung-Ki Kim1,2.   

Abstract

Background and Purpose- In pediatric moyamoya disease, there are few reports on the efficacy of surgical intervention for stroke prevention. We evaluated the long-term outcomes of indirect bypass surgery on a relatively large number of children with moyamoya disease in a single center. Methods- From August 1988 to December 2012, 772 children underwent indirect bypass surgery. This study included 629 patients who were followed up for >5 years, excluding patients with moyamoya syndrome. The mean clinical follow-up duration was 12 years (range, 5-29 years). Cross-sectional analysis was performed based on either Karnofsky Performance Scale or Lansky Play Performance Scale to evaluate overall clinical outcomes and factors associated with unfavorable outcomes. To analyze the longitudinal effect of surgery, the annual risk of symptomatic infarction or hemorrhage on the operated hemisphere after indirect bypass surgery was calculated with a person-year method, and the event-free survival rate was evaluated using the Kaplan-Meier method. Results- The overall clinical outcome was favorable in 95% of the patients. The annual risks of symptomatic infarction and hemorrhage on the operated hemispheres were 0.08% and 0.04%, respectively. Furthermore, the 10-year event-free survival rates for symptomatic infarction and hemorrhage were 99.2% and 99.8%. Conclusions- Indirect bypass surgery could provide satisfactory long-term improvement in overall clinical outcome and prevention of recurrent stroke in children with moyamoya disease.

Entities:  

Keywords:  assessment, outcome; cerebral revascularization surgery; child; moyamoya disease; stroke

Mesh:

Year:  2019        PMID: 31551037     DOI: 10.1161/STROKEAHA.119.025609

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Preoperative Collateral Perfusion Using Arterial Spin Labeling: A Predictor of Surgical Collaterals in Moyamoya Angiopathy.

Authors:  Maoxue Wang; Yi Wang; Wen Zhang; Xiance Zhao; Yongbo Yang; Bing Zhang
Journal:  Front Neurosci       Date:  2022-03-14       Impact factor: 4.677

2.  Daily Remote Ischemic Conditioning Can Improve Cerebral Perfusion and Slow Arterial Progression of Adult Moyamoya Disease-A Randomized Controlled Study.

Authors:  Jiali Xu; Qian Zhang; Gary B Rajah; Wenbo Zhao; Fang Wu; Yuchuan Ding; Bowei Zhang; Wenting Guo; Qi Yang; Xiurong Xing; Sijie Li; Xunming Ji
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

3.  Infarction Patterns and Recurrent Adverse Cerebrovascular Events in Moyamoya Disease.

Authors:  Shao-Chen Yu; Zi-Han Yin; Chao-Fan Zeng; Fa Lin; Long Ma; Yan Zhang; Dong Zhang; Ji-Zong Zhao
Journal:  Dis Markers       Date:  2022-03-29       Impact factor: 3.434

4.  Clinical significance of asymmetric venous vasculature on minimum-intensity projection in patients with moyamoya disease.

Authors:  Min Jeong Han; Sun Jun Kim
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

5.  Current trends in pediatric moyamoya: a survey of international practitioners.

Authors:  Harishchandra Lalgudi Srinivasan; Moran Hausman-Kedem; Edward R Smith; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2021-03-10       Impact factor: 1.475

6.  Risk factors for postoperative ischemic complications in pediatric moyamoya disease.

Authors:  Xiaofeng Deng; Peicong Ge; Rong Wang; Dong Zhang; Jizong Zhao; Yan Zhang
Journal:  BMC Neurol       Date:  2021-06-22       Impact factor: 2.474

Review 7.  Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome.

Authors:  Pietro Fiaschi; Marcello Scala; Gianluca Piatelli; Domenico Tortora; Francesca Secci; Armando Cama; Marco Pavanello
Journal:  Neurosurg Rev       Date:  2020-09-21       Impact factor: 3.042

Review 8.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.